308 related articles for article (PubMed ID: 19188497)
1. CD4+ regulatory T cells require CTLA-4 for the maintenance of systemic tolerance.
Friedline RH; Brown DS; Nguyen H; Kornfeld H; Lee J; Zhang Y; Appleby M; Der SD; Kang J; Chambers CA
J Exp Med; 2009 Feb; 206(2):421-34. PubMed ID: 19188497
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4 suppresses the pathogenicity of self antigen-specific T cells by cell-intrinsic and cell-extrinsic mechanisms.
Ise W; Kohyama M; Nutsch KM; Lee HM; Suri A; Unanue ER; Murphy TL; Murphy KM
Nat Immunol; 2010 Feb; 11(2):129-35. PubMed ID: 20037585
[TBL] [Abstract][Full Text] [Related]
3. Dual function of CTLA-4 in regulatory T cells and conventional T cells to prevent multiorgan autoimmunity.
Jain N; Nguyen H; Chambers C; Kang J
Proc Natl Acad Sci U S A; 2010 Jan; 107(4):1524-8. PubMed ID: 20080649
[TBL] [Abstract][Full Text] [Related]
4. Expression of CTLA-4 and FOXP3 in cis protects from lethal lymphoproliferative disease.
Chikuma S; Bluestone JA
Eur J Immunol; 2007 May; 37(5):1285-9. PubMed ID: 17429849
[TBL] [Abstract][Full Text] [Related]
5. Enhanced selection of FoxP3+ T-regulatory cells protects CTLA-4-deficient mice from CNS autoimmune disease.
Verhagen J; Gabrysová L; Minaee S; Sabatos CA; Anderson G; Sharpe AH; Wraith DC
Proc Natl Acad Sci U S A; 2009 Mar; 106(9):3306-11. PubMed ID: 19218450
[TBL] [Abstract][Full Text] [Related]
6. B7+ iris pigment epithelial cells convert T cells into CTLA-4+, B7-expressing CD8+ regulatory T cells.
Sugita S; Keino H; Futagami Y; Takase H; Mochizuki M; Stein-Streilein J; Streilein JW
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5376-84. PubMed ID: 17122127
[TBL] [Abstract][Full Text] [Related]
7. Immune tolerance to self-major histocompatibility complex class II antigens after bone marrow transplantation: role of regulatory T cells.
Hess AD; Thoburn CJ
Biol Blood Marrow Transplant; 2006 May; 12(5):518-29. PubMed ID: 16635787
[TBL] [Abstract][Full Text] [Related]
8. The potential effect and mechanism of high-mobility group box 1 protein on regulatory T cell-mediated immunosuppression.
Zhang Y; Yao YM; Huang LF; Dong N; Yu Y; Sheng ZY
J Interferon Cytokine Res; 2011 Feb; 31(2):249-57. PubMed ID: 21087077
[TBL] [Abstract][Full Text] [Related]
9. Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice.
Serr I; Fürst RW; Achenbach P; Scherm MG; Gökmen F; Haupt F; Sedlmeier EM; Knopff A; Shultz L; Willis RA; Ziegler AG; Daniel C
Nat Commun; 2016 Mar; 7():10991. PubMed ID: 26975663
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of the Foxp3-dependent developmental program in mature regulatory T cells requires continued expression of Foxp3.
Williams LM; Rudensky AY
Nat Immunol; 2007 Mar; 8(3):277-84. PubMed ID: 17220892
[TBL] [Abstract][Full Text] [Related]
11. Imbalanced signal transduction in regulatory T cells expressing the transcription factor FoxP3.
Yan D; Farache J; Mingueneau M; Mathis D; Benoist C
Proc Natl Acad Sci U S A; 2015 Dec; 112(48):14942-7. PubMed ID: 26627244
[TBL] [Abstract][Full Text] [Related]
12. Enhanced engagement of CTLA-4 induces antigen-specific CD4+CD25+Foxp3+ and CD4+CD25- TGF-beta 1+ adaptive regulatory T cells.
Li R; Perez N; Karumuthil-Melethil S; Prabhakar BS; Holterman MJ; Vasu C
J Immunol; 2007 Oct; 179(8):5191-203. PubMed ID: 17911604
[TBL] [Abstract][Full Text] [Related]
13. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells.
Razmara M; Hilliard B; Ziarani AK; Chen YH; Tykocinski ML
Int Immunol; 2008 Apr; 20(4):471-83. PubMed ID: 18272926
[TBL] [Abstract][Full Text] [Related]
14. CTLA-4 control over Foxp3+ regulatory T cell function.
Wing K; Onishi Y; Prieto-Martin P; Yamaguchi T; Miyara M; Fehervari Z; Nomura T; Sakaguchi S
Science; 2008 Oct; 322(5899):271-5. PubMed ID: 18845758
[TBL] [Abstract][Full Text] [Related]
15. Tumor Progression Locus 2 (Tpl2) Activates the Mammalian Target of Rapamycin (mTOR) Pathway, Inhibits Forkhead Box P3 (FoxP3) Expression, and Limits Regulatory T Cell (Treg) Immunosuppressive Functions.
Li X; Acuff NV; Peeks AR; Kirkland R; Wyatt KD; Nagy T; Watford WT
J Biol Chem; 2016 Aug; 291(32):16802-15. PubMed ID: 27261457
[TBL] [Abstract][Full Text] [Related]
16. Conversion of Anergic T Cells Into Foxp3
Thomann AS; Schneider T; Cyran L; Eckert IN; Kerstan A; Lutz MB
Front Immunol; 2021; 12():704578. PubMed ID: 34249012
[TBL] [Abstract][Full Text] [Related]
17. Foxp3 processing by proprotein convertases and control of regulatory T cell function.
de Zoeten EF; Lee I; Wang L; Chen C; Ge G; Wells AD; Hancock WW; Ozkaynak E
J Biol Chem; 2009 Feb; 284(9):5709-16. PubMed ID: 19117830
[TBL] [Abstract][Full Text] [Related]
18. Nonself-antigens are the cognate specificities of Foxp3+ regulatory T cells.
Pacholczyk R; Kern J; Singh N; Iwashima M; Kraj P; Ignatowicz L
Immunity; 2007 Sep; 27(3):493-504. PubMed ID: 17869133
[TBL] [Abstract][Full Text] [Related]
19. Only the CD45RA+ subpopulation of CD4+CD25high T cells gives rise to homogeneous regulatory T-cell lines upon in vitro expansion.
Hoffmann P; Eder R; Boeld TJ; Doser K; Piseshka B; Andreesen R; Edinger M
Blood; 2006 Dec; 108(13):4260-7. PubMed ID: 16917003
[TBL] [Abstract][Full Text] [Related]
20. High TCR diversity ensures optimal function and homeostasis of Foxp3+ regulatory T cells.
Föhse L; Suffner J; Suhre K; Wahl B; Lindner C; Lee CW; Schmitz S; Haas JD; Lamprecht S; Koenecke C; Bleich A; Hämmerling GJ; Malissen B; Suerbaum S; Förster R; Prinz I
Eur J Immunol; 2011 Nov; 41(11):3101-13. PubMed ID: 21932448
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
